MiR-129-5p alleviates depression and anxiety by increasing astrocyte ATP production partly through targeting deubiquitinase Mysm1
PLOS One · 2025
DOI: 10.1371/journal.pone.0322715 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Qiaozhen Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Basic Medical Sciences, Haidian, Beijing, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Astrocytes, Adenosine Triphosphate, Anxiety. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation.
Themen: Depression
Abstract (Originalsprache)
Major depressive disorder (MDD) is a major global mental concern that severely affects quality of life, yet current pharmacological treatments remain limited in their effectiveness. Long-term chronic stress has been shown to increase the incidence of depression and anxiety. Micro RNAs (miRNAs) have been revealed to participate in the pathological process of depression and represent promising therapeutic targets. In this study, we found that microRNA-129-5p (miR-129-5p) was significantly decreased in the brains of depressive mice. Overexpression of miR-129-5p in the hippocampus effectively alleviated depressive-like behaviors and reduced the activation of microglial cells and astrocytes. In addition, ATP levels in depressive mice were significantly increased following miR-129-5p overexpression. The antidepressant effects of miR-129-5p were reversed when ATP function was blocked with the non-specific P2 receptor antagonist suramin. In vitro experiments revealed that miR-129-5p overexpression enhanced ATP production in astrocytes. Furthermore, using a dual-luciferase reporter assay, we found that miR-129-5p directly targeted Mysm1. When overexpressed in astrocytes, miR-129-5p significantly suppressed Mysm1 expression, promoted phosphorylation of p53 and AMPK, and enhanced the expression of PGC1α, factors previously associated with ATP production. Our findings highlight the crucial role of miR-129-5p in regulating depression, suggesting that miR-129-5p overexpression may serve as an effective strategy for antidepressant treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Basic Medical Sciences, Haidian, Beijing, P.R. China.
- Beijing International Science and Technology Cooperation Base for Antiviral Drugs, Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Bei…
- Anhui Medical University, Hefei, Anhui, China.
- Jishou University, Jishou, Hunan, China.
ORCID-Profile: Qiaozhen Qin
Förderung
- Beijing Natural Science Foundation
Zitieren
APA
Qin, Q., Zhang, H., Li, X., Ruan, H., Liu, S., Chen, Y., Xu, Z., Wang, Y., Yan, X., & Jiang, X. (2025). MiR-129-5p alleviates depression and anxiety by increasing astrocyte ATP production partly through targeting deubiquitinase Mysm1. PLOS One. https://doi.org/10.1371/journal.pone.0322715
Vancouver
Qin Q, Zhang H, Li X, Ruan H, Liu S, Chen Y, et al. MiR-129-5p alleviates depression and anxiety by increasing astrocyte ATP production partly through targeting deubiquitinase Mysm1. PLOS One. 2025. doi:10.1371/journal.pone.0322715
BibTeX
@article{Qin2025,
author = {Qin, Qiaozhen and Zhang, Heyang and Li, Xiaotong and Ruan, Huaqiang and Liu, Shuirong and Chen, Yue and Xu, Zhenhua and Wang, Yan and Yan, Xinlong and Jiang, Xiaoxia},
title = {MiR-129-5p alleviates depression and anxiety by increasing astrocyte ATP production partly through targeting deubiquitinase Mysm1},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0322715}
}
EUVIMED